These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 26123478)
1. Therapeutic plasma exchange as a therapeutic modality for the treatment of IVIG complications. Welsh KJ; Bai Y J Clin Apher; 2015 Dec; 30(6):371-4. PubMed ID: 26123478 [TBL] [Abstract][Full Text] [Related]
2. Specifications for anti-A and anti-B in intravenous immunoglobulin: history and rationale. Thorpe SJ Transfusion; 2015 Jul; 55 Suppl 2():S80-5. PubMed ID: 26174902 [TBL] [Abstract][Full Text] [Related]
3. Possible mechanisms for intravenous immunoglobulin-associated hemolysis: clues obtained from review of clinical case reports. Padmore R Transfusion; 2015 Jul; 55 Suppl 2():S59-64. PubMed ID: 26174898 [TBL] [Abstract][Full Text] [Related]
4. Acute hemolysis after intravenous immunoglobulin amid host factors of ABO-mismatched bone marrow transplantation, inflammation, and activated mononuclear phagocytes. Michelis FV; Branch DR; Scovell I; Bloch E; Pendergrast J; Lipton JH; Cserti-Gazdewich CM Transfusion; 2014 Mar; 54(3):681-90. PubMed ID: 23829192 [TBL] [Abstract][Full Text] [Related]
5. Emergency ABO-incompatible liver transplant secondary to fulminant hepatic failure: outcome, role of TPE and review of the literature. Maitta RW; Choate J; Emre SH; Luczycki SM; Wu Y J Clin Apher; 2012; 27(6):320-9. PubMed ID: 22833397 [TBL] [Abstract][Full Text] [Related]
6. Hemolysis related to intravenous immunoglobulins is dependent on the presence of anti-blood group A and B antibodies and individual susceptibility. Mielke O; Fontana S; Goranova-Marinova V; Shebl A; Spycher MO; Wymann S; Durn BL; Lawo JP; Hubsch A; Salama A Transfusion; 2017 Nov; 57(11):2629-2638. PubMed ID: 28840942 [TBL] [Abstract][Full Text] [Related]
7. Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients. Kahwaji J; Barker E; Pepkowitz S; Klapper E; Villicana R; Peng A; Chang R; Jordan SC; Vo AA Clin J Am Soc Nephrol; 2009 Dec; 4(12):1993-7. PubMed ID: 19833910 [TBL] [Abstract][Full Text] [Related]
8. Haemolysis after treatment with intravenous immunoglobulin due to anti-A. Morgan S; Sorensen P; Vercellotti G; Zantek ND Transfus Med; 2011 Aug; 21(4):267-70. PubMed ID: 21605202 [TBL] [Abstract][Full Text] [Related]
9. Anti-A and anti-B: what are they and where do they come from? Branch DR Transfusion; 2015 Jul; 55 Suppl 2():S74-9. PubMed ID: 26174901 [TBL] [Abstract][Full Text] [Related]
10. A prospective observational study of the incidence, natural history, and risk factors for intravenous immunoglobulin-mediated hemolysis. Pendergrast J; Armali C; Callum J; Cserti-Gazdewich C; Jiwajee A; Lieberman L; Lau W; Lin Y; Parmar N; Pavenski K; Riden LS; Shehata N; Willie-Ramharack K; Tomlinson G; Tong TN; Binnington B; Branch DR; Transfusion; 2021 Apr; 61(4):1053-1063. PubMed ID: 33433931 [TBL] [Abstract][Full Text] [Related]
11. The role of inflammation in intravenous immune globulin-mediated hemolysis. Pendergrast J; Willie-Ramharack K; Sampson L; Laroche V; Branch DR Transfusion; 2015 Jul; 55 Suppl 2():S65-73. PubMed ID: 26174900 [TBL] [Abstract][Full Text] [Related]
12. The critical role of plasmapheresis in ABO-incompatible renal transplantation. Tobian AA; Shirey RS; Montgomery RA; Ness PM; King KE Transfusion; 2008 Nov; 48(11):2453-60. PubMed ID: 18657072 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic plasma exchange for desensitization prior to transplantation in ABO-incompatible renal allografts. Sivakumaran P; Vo AA; Villicana R; Peng A; Jordan SC; Pepkowitz SH; Klapper EB J Clin Apher; 2009; 24(4):155-60. PubMed ID: 19658162 [TBL] [Abstract][Full Text] [Related]
14. Acute hemolysis in a patient with cytomegalovirus pneumonitis treated with intravenous immunoglobulin (IVIG). Coghill J; Comeau T; Shea T; Braddy L; Bandarenko N; Afenyi-Annan A; Harvey D Biol Blood Marrow Transplant; 2006 Jul; 12(7):786-8. PubMed ID: 16785068 [No Abstract] [Full Text] [Related]
15. Antibody removal before ABO-incompatible renal transplantation: how much plasma exchange is therapeutic? Lawrence C; Galliford JW; Willicombe MK; McLean AG; Lesabe M; Rowan F; Papalois V; Regan F; Taube D Transplantation; 2011 Nov; 92(10):1129-33. PubMed ID: 21959216 [TBL] [Abstract][Full Text] [Related]
16. Hemolytic adverse effects of intravenous immunoglobulin: modeling predicts risk reduction with anti-A/B immunoaffinity chromatography and to a lesser extent with anti-A donor screening. Mallick R; Hubsch A; Barnes DG Transfusion; 2018 Dec; 58(12):2752-2756. PubMed ID: 30284263 [TBL] [Abstract][Full Text] [Related]
17. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation. Ikegami T; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Harada N; Iguchi T; Hashimoto N; Maehara Y Transplantation; 2009 Aug; 88(3):303-7. PubMed ID: 19667930 [TBL] [Abstract][Full Text] [Related]